Difference between revisions of "Part:BBa K5398020:Experience"
(→Protein Expression) |
(→Adhesive test) |
||
(16 intermediate revisions by the same user not shown) | |||
Line 9: | Line 9: | ||
===Characterization=== | ===Characterization=== | ||
− | In order to obtain proteins, test suitable expression conditions, and evaluate the function of TRn4-mfp5, we chose three different expression vectors (Fig. | + | In order to obtain proteins, test suitable expression conditions, and evaluate the function of TRn4-mfp5, we chose three different expression vectors (Fig. 1)—pET-28a(+), pET-SUMO, and pET-21a(+)—and tried different strategies for TRn4-mfp5 protein production and purification. |
+ | |||
<html lang="zh"> | <html lang="zh"> | ||
Line 36: | Line 37: | ||
</body> | </body> | ||
</html> | </html> | ||
+ | |||
+ | ====Protein Expression==== | ||
+ | <p>We expressed the protein in <i>E. coli </i> BL21(DE3) using LB medium. After incubation at 16°C for 20 h or at 37°C for 4 h, we found that the protein expressed better under the 16°C for 20 h condition, as indicated by the stronger bands in Fig. 2. This suggests that lower temperature incubation may enhance protein solubility and proper folding, resulting in improved yield. | ||
+ | <html lang="zh"> | ||
+ | <head> | ||
+ | <meta charset="UTF-8"> | ||
+ | <meta name="viewport" content="width=device-width, initial-scale=1.0"> | ||
+ | <style> | ||
+ | .module { | ||
+ | border: 1px solid #ccc; /* 边框 / | ||
+ | padding: 20px; /* 内边距 / | ||
+ | margin: 20px auto; /* 外边距,自动居中 / | ||
+ | width: 800px; /* 模块宽度 / | ||
+ | text-align: center; /* 内容居中 / | ||
+ | box-shadow: 0px 0px 10px rgba(0, 0, 0, 0.1); /* 阴影效果 */ | ||
+ | } | ||
+ | </style> | ||
+ | </head> | ||
+ | <body> | ||
+ | <div class="module"> | ||
+ | <img src="https://static.igem.wiki/teams/5398/trn4-mfp5/16-37-lb-pet21a-new.webp" width="700" height="auto" alt="Protein purification"> | ||
+ | <p><b>Fig. 2 | Comparison of fusion protein expression in different temperature use vector pET-21a(+).</b></p> | ||
+ | <p> | ||
+ | Lane 1: Protein ladder; Lanes 2-7 (LB 37°C 4 h): Lane 2: Total liquid (IPTG); Lane 3: Supernatant | ||
+ | (IPTG); Lane 4: Precipitate (IPTG); Lane 5: Total liquid; Lane 6: Supernatant; Lane 7: Precipitate; | ||
+ | Lanes 8-13 (TB 16°C 20 h): Lane 8: Total liquid (IPTG); Lane 9: Supernatant (IPTG); Lane 10: | ||
+ | Precipitate (IPTG); Lane 11: Total liquid; Lane 12: Supernatant; Lane 13: Precipitate; Lane 14: | ||
+ | Protein ladder. </p> | ||
+ | </div> | ||
+ | </body> | ||
+ | </html> | ||
+ | |||
+ | |||
+ | Since there was some discrepancy in the target band size observed in the SDS-PAGE gel, and the bands were not very distinct, we also tried another medium in an attempt to increase the expression level of the fusion protein. We additionally used TB medium and compared its expression efficiency with that of LB medium. We found that the bands in the TB medium were indeed thicker than those in the LB medium, indicating a slight increase in expression levels, although the difference was not significant. | ||
+ | </p> | ||
<html lang="zh"> | <html lang="zh"> | ||
<head> | <head> | ||
Line 48: | Line 84: | ||
text-align: center; /* 内容居中 */ | text-align: center; /* 内容居中 */ | ||
box-shadow: 0px 0px 10px rgba(0, 0, 0, 0.1); /* 阴影效果 */ | box-shadow: 0px 0px 10px rgba(0, 0, 0, 0.1); /* 阴影效果 */ | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
} | } | ||
</style> | </style> | ||
Line 61: | Line 89: | ||
<body> | <body> | ||
<div class="module"> | <div class="module"> | ||
− | + | <img src="https://static.igem.wiki/teams/5398/trn4-mfp5/tb-lb-prt21a-new.webp" width="700" height="auto" alt="Protein purification"> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | <img src="https://static.igem.wiki/teams/5398/trn4-mfp5/tb-lb-prt21a.webp" width="700" height="auto" alt="Protein purification"> | + | |
<p><b>Fig. 3 | Comparison of fusion protein expression in LB and TB media use vector pET-21a(+).</b></p> | <p><b>Fig. 3 | Comparison of fusion protein expression in LB and TB media use vector pET-21a(+).</b></p> | ||
<p> | <p> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | + | Lanes 1-6 (LB 16°C 20 h): Lane 1: Total liquid (IPTG); Lane 2: Supernatant (IPTG); Lane 3: | |
− | + | Precipitate (IPTG); Lane 4: Total liquid; Lane 5: Supernatant; Lane 6: Precipitate; Lane 7: Protein | |
− | + | ladder; Lanes 8-13 (TB 16°C 20 h): Lane 8: Total liquid (IPTG); Lane 9: Supernatant (IPTG); Lane | |
− | + | 10: Precipitate (IPTG); Lane 11: Total liquid; Lane 12: Supernatant; Lane 13: Precipitate. | |
− | + | ||
− | + | </p> | |
− | + | ||
− | + | ||
− | + | ||
</div> | </div> | ||
+ | </body> | ||
+ | </html> | ||
+ | We compared protein expression between the BL21(DE3) and Rosetta <i>E. coli </i> strains. Rosetta, derived from BL21, includes a compatible chloramphenicol-resistant plasmid that provides tRNA genes for six rare codons (AUA, AGG, AGA, CUA, CCC, GGA) that are often underrepresented in <i>E. coli </i>. This modification is designed to overcome expression limitations when eukaryotic genes, which frequently use these rare codons, are expressed in a prokaryotic system. We used the pET-SUMO vector for expression.<br> | ||
+ | While Rosetta is optimized to address these rare codon issues and can be advantageous when expressing eukaryotic proteins with high rare codon usage, our results showed that protein expression levels were higher in the BL21(DE3) strain. This discrepancy could be due to several factors. One possibility is that our target protein does not contain a sufficient number of rare codons to significantly hinder translation in BL21(DE3). Additionally, the extra plasmid load in Rosetta could impose a metabolic burden, reducing its overall protein production efficiency. As a result, in cases where rare codon usage is not a critical factor, BL21(DE3) might provide a more efficient platform for protein expression.<br> | ||
+ | |||
+ | The results indicate that the protein expression level in the BL21(DE3) strain is higher compared to that in the Rosetta strain.<br> | ||
+ | <html lang="zh"> | ||
+ | <head> | ||
+ | <meta charset="UTF-8"> | ||
+ | <meta name="viewport" content="width=device-width, initial-scale=1.0"> | ||
+ | <style> | ||
+ | .module { | ||
+ | border: 1px solid #ccc; /* 边框 */ | ||
+ | padding: 20px; /* 内边距 */ | ||
+ | margin: 20px auto; /* 外边距,自动居中 */ | ||
+ | width: 800px; /* 模块宽度 */ | ||
+ | text-align: center; /* 内容居中 */ | ||
+ | box-shadow: 0px 0px 10px rgba(0, 0, 0, 0.1); /* 阴影效果 */ | ||
+ | } | ||
+ | </style> | ||
+ | </head> | ||
+ | <body> | ||
<div class="module"> | <div class="module"> | ||
− | <img src="https://static.igem.wiki/teams/5398/trn4-mfp5/rostta-bl21-de3-trn4- | + | <img src="https://static.igem.wiki/teams/5398/trn4-mfp5/rostta-bl21-de3-trn4-mfp-new.webp" width="700" height="auto" alt="Protein purification"> |
<p><b>Fig. 4 | Comparison of fusion protein expression in <i>E. coli</i> strains BL21(DE3) and Rosetta.</b></p> | <p><b>Fig. 4 | Comparison of fusion protein expression in <i>E. coli</i> strains BL21(DE3) and Rosetta.</b></p> | ||
<p> | <p> | ||
− | + | Lane 1: Protein ladder; Lanes 2-4 (BL21(DE3) LB 37℃ 4 h): Lane 2: Total liquid (IPTG); | |
− | + | Lane 3: Supernatant (IPTG); Lane 4: Precipitate (IPTG); Lanes 5-7 (Rosetta LB 37℃ 4 h) Lane 5: | |
− | + | Total liquid (IPTG); Lane 6: Supernatant (IPTG); Lane 7: Precipitate (IPTG) | |
− | + | </p> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</div> | </div> | ||
</body> | </body> | ||
Line 126: | Line 136: | ||
====Protein Purification==== | ====Protein Purification==== | ||
− | After considering both expression efficiency and practical experimental constraints, we decided to express the fusion protein at 37°C for 4 h in LB medium using the pET-SUMO-TRn4-mfp5 plasmid.< | + | <p> |
− | + | After considering both expression efficiency and practical experimental constraints, we decided to express the fusion protein at 37°C for 4 h in LB medium using the pET-SUMO-TRn4-mfp5 plasmid.<br> | |
− | + | As shown in Figures 2-4, the target protein was present in the pellet after cell lysis. Therefore, we denatured the pellet of the fusion protein TRn4-mfp5 with 8M urea overnight and renatured it through dialysis. This process resulted in some protein loss, as confirmed by SDS-PAGE analysis. <br> | |
− | + | Consequently, we proceeded to purify the fusion protein TRn4-mfp5 using a Ni-NTA Gravity Column.<br> | |
+ | The target protein bands were present in lanes 2 to 5, indicating successful expression of the target protein, with a particularly strong band in the supernatant after denaturation (Fig. 5, lane 7). After purification, the target protein was mainly found in the 150 mM and 300 mM imidazole elution fractions.</p> | ||
<html lang="zh"> | <html lang="zh"> | ||
Line 148: | Line 159: | ||
<body> | <body> | ||
<div class="module"> | <div class="module"> | ||
− | <img src="https://static.igem.wiki/teams/5398/trn4-mfp5/purification-trn4-mfp5.webp" width="700" height="auto" alt="Protein purification"> | + | <img src="https://static.igem.wiki/teams/5398/trn4-mfp5/purification-trn4-mfp5-new.webp" width="700" height="auto" alt="Protein purification"> |
<p><b>Fig. 5 | SDS-PAGE of purified fusion protein TRn4-mfp5(35.4 kDa) uses vector pET-SUMO.</b></p> | <p><b>Fig. 5 | SDS-PAGE of purified fusion protein TRn4-mfp5(35.4 kDa) uses vector pET-SUMO.</b></p> | ||
<p> | <p> | ||
− | Lane 1: Protein - Binding buffer; | + | Lane 1: Protein-Binding buffer; Lane 2: 20 mM imidazole and 8 M urea elution; Lane 3: 50 mM |
− | Lane 2: 20 mM imidazole and 8 M urea elution; | + | imidazole and 8 M urea elution; Lane 4: 150 mM imidazole and 8 M urea elution; Lane 5: 300 mM |
− | Lane 3: 50 mM imidazole and 8 M urea elution; | + | imidazole and 8 M urea elution; Lane 6: 500 mM imidazole and 8 M urea elution; Lane 7: |
− | Lane 4: 150 mM imidazole and 8 M urea elution; | + | Supernatant; Lane 8: Impurities; Lane 9: Protein ladder. |
− | Lane 5: 300 mM imidazole and 8 M urea elution; | + | |
− | Lane 6: 500 mM imidazole and 8 M urea elution; | + | |
− | Lane 7: Supernatant; | + | |
− | Lane 8: Impurities; | + | |
− | Lane 9: Protein ladder. | + | |
</p> | </p> | ||
</div> | </div> | ||
Line 165: | Line 171: | ||
</html> | </html> | ||
− | + | To further confirm the expression of TRn4-mfp5, we performed a Western blot, which provided a clear and definitive conclusion, verifying the successful expression of the TRn4-mfp5 protein under the conditions mentioned above. | |
<html lang="zh"> | <html lang="zh"> | ||
Line 184: | Line 190: | ||
<body> | <body> | ||
<div class="module"> | <div class="module"> | ||
− | <img src="https://static.igem.wiki/teams/5398/trn4-mfp5/wb- | + | <img src="https://static.igem.wiki/teams/5398/trn4-mfp5/wb-new.webp" width="700" height="auto" alt="Protein purification"> |
<p><b>Fig. 6 | Western Blot of purified fusion protein TRn4-mfp5(35.4 kDa) uses vector pET-SUMO.</b></p> | <p><b>Fig. 6 | Western Blot of purified fusion protein TRn4-mfp5(35.4 kDa) uses vector pET-SUMO.</b></p> | ||
<p> | <p> | ||
− | <p><b>a.</b> | + | <p> |
+ | <b>a.</b> Western blot of the pre-expressed protein. Lane 1: Total liquid (IPTG); Lane 2: | ||
+ | Supernatant (IPTG); Lane 3: Precipitate (IPTG), <b>b.</b> Western blot after column purification | ||
+ | of the supernatant following denaturation. Lane 1: Supernatant; Lane 2: 20 mM imidazole and 8 | ||
+ | M urea elution; Lane 3: 50 mM imidazole and 8 M urea elution; Lane 4: 150 mM imidazole and 8 M | ||
+ | urea elution; Lane 5: 300 mM imidazole and 8 M urea elution; Lane 6: 500 mM imidazole and 8 M | ||
+ | urea elution. | ||
</p> | </p> | ||
</div> | </div> | ||
Line 194: | Line 206: | ||
====Adhesive test==== | ====Adhesive test==== | ||
− | We obtained protein samples of TRn4-mfp5 by freezedrying 24 h (Fig. | + | We obtained protein samples of TRn4-mfp5 by freezedrying 24 h (Fig. 7). We finally got about 25 mg protein from 1 L bacterial culture. |
<html lang="zh"> | <html lang="zh"> | ||
<head> | <head> | ||
Line 218: | Line 230: | ||
</html> | </html> | ||
− | Next, we dissolved protein samples in Buffer A (10 mL 20 mM Tris | + | Next, we dissolved protein samples in Buffer A (10 mL 20 mM Tris pH = 8) to reach 0.3 mg/mL, and conduct adhesive ability tests on the fusion protein(Fig. 8). 20 μL of the protein solution was applied, and the pipette tip was placed on a plastic Petri dish lid. After incubation at 37°C for 4 h, the pipette tip successfully adhered. |
<html lang="zh"> | <html lang="zh"> | ||
Line 242: | Line 254: | ||
</body> | </body> | ||
</html> | </html> | ||
+ | |||
+ | https://video.igem.org/videos/embed/76ade119-0738-4ded-9b7e-1af2e0326a27 | ||
+ | <p><b>Video. 1 | NAU-CHINA: TRn4-mfp5 adhesive ability test (2024)</b></p> | ||
<html lang="en"> | <html lang="en"> | ||
Line 264: | Line 279: | ||
<b>Viscosity Calculations</b> | <b>Viscosity Calculations</b> | ||
− | <p>Surface Area Calculation:</p> | + | <p><b>Surface Area Calculation:</b></p> |
− | <p>The surface area of | + | <p>The surface area for the annular region of the pipette tip is calculated as:</p> |
− | < | + | <p> |
− | + | <strong>S</strong> = π × (r<sub>outer</sub><sup>2</sup> - r<sub>inner</sub> | |
− | </ | + | <sup>2</sup>) |
− | + | </p> | |
− | <p>Force Calculation:</p> | + | <p> |
− | <p>The total | + | Where: <br>r<sub>outer</sub> = 3 mm = 0.3 cm <br> |
− | < | + | r<sub>inner</sub> = 1.85 mm = 0.185 cm |
− | + | </p> | |
− | < | + | <p> |
− | + | Substituting these values, we get: | |
− | < | + | </p> |
− | <p>The adhesive force produced by the protein is:</p> | + | <p> |
− | < | + | <strong>S</strong> = π × (0.3<sup>2</sup> - 0.185<sup>2</sup>) = π × (0.09 - 0.034225) = |
− | + | π × 0.055775 ≈ 0.1753 cm<sup>2</sup> | |
− | </ | + | </p> |
+ | <p><b>Force Calculation:</b></p> | ||
+ | <p>The total force is calculated as:</p> | ||
+ | <p> | ||
+ | <strong>F</strong> = (5.951 + 0.448 × 15) g × 9.8 N/kg = 12.671 g × 9.8 N/kg ≈ 0.12418 N | ||
+ | </p> | ||
+ | <p><b>Adhesive Force Calculation:</b></p> | ||
+ | <p>The adhesive force produced by the protein is:</p> | ||
+ | <p> | ||
+ | <strong>P</strong> = <strong>F</strong> / <strong>S</strong> = 0.12418 N / 0.1753 | ||
+ | cm<sup>2</sup> ≈ 0.708 N/cm<sup>2</sup> = 7.08 kPa | ||
+ | </p> | ||
+ | <p><b>Adhesive Force per Milligram of Protein:</b></p> | ||
+ | <p>The adhesive force per milligram of protein is:</p> | ||
+ | <p> | ||
+ | <strong>P'</strong> = <strong>P</strong> / m = 7.08 kPa / 1 mg = 7.08 kPa/mg | ||
+ | </p> | ||
− | |||
− | |||
− | |||
− | |||
</div> | </div> | ||
Latest revision as of 16:21, 1 October 2024
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_K5398020
In order to obtain proteins with adhesive properties, we used the pET-SUMO vector to express TRn4-mfp5 ( BBa_K5398020) ). We tried different strategies for TRn4-mfp5 protein production and purification and tested its function.
Characterization
In order to obtain proteins, test suitable expression conditions, and evaluate the function of TRn4-mfp5, we chose three different expression vectors (Fig. 1)—pET-28a(+), pET-SUMO, and pET-21a(+)—and tried different strategies for TRn4-mfp5 protein production and purification.
Fig. 1 | Three different vectors used in protein expression.
a. The plasmid map of pET-28a(+)-His-SUMO-TRn4-mfp5; b. The plasmid map of pET-SUMO-TRn4-mfp5; c. The plasmid map of pET-21a(+)-TRn4-mfp5.
Protein Expression
We expressed the protein in E. coli BL21(DE3) using LB medium. After incubation at 16°C for 20 h or at 37°C for 4 h, we found that the protein expressed better under the 16°C for 20 h condition, as indicated by the stronger bands in Fig. 2. This suggests that lower temperature incubation may enhance protein solubility and proper folding, resulting in improved yield.
Fig. 2 | Comparison of fusion protein expression in different temperature use vector pET-21a(+).
Lane 1: Protein ladder; Lanes 2-7 (LB 37°C 4 h): Lane 2: Total liquid (IPTG); Lane 3: Supernatant (IPTG); Lane 4: Precipitate (IPTG); Lane 5: Total liquid; Lane 6: Supernatant; Lane 7: Precipitate; Lanes 8-13 (TB 16°C 20 h): Lane 8: Total liquid (IPTG); Lane 9: Supernatant (IPTG); Lane 10: Precipitate (IPTG); Lane 11: Total liquid; Lane 12: Supernatant; Lane 13: Precipitate; Lane 14: Protein ladder.
Fig. 3 | Comparison of fusion protein expression in LB and TB media use vector pET-21a(+).
Lanes 1-6 (LB 16°C 20 h): Lane 1: Total liquid (IPTG); Lane 2: Supernatant (IPTG); Lane 3: Precipitate (IPTG); Lane 4: Total liquid; Lane 5: Supernatant; Lane 6: Precipitate; Lane 7: Protein ladder; Lanes 8-13 (TB 16°C 20 h): Lane 8: Total liquid (IPTG); Lane 9: Supernatant (IPTG); Lane 10: Precipitate (IPTG); Lane 11: Total liquid; Lane 12: Supernatant; Lane 13: Precipitate.
While Rosetta is optimized to address these rare codon issues and can be advantageous when expressing eukaryotic proteins with high rare codon usage, our results showed that protein expression levels were higher in the BL21(DE3) strain. This discrepancy could be due to several factors. One possibility is that our target protein does not contain a sufficient number of rare codons to significantly hinder translation in BL21(DE3). Additionally, the extra plasmid load in Rosetta could impose a metabolic burden, reducing its overall protein production efficiency. As a result, in cases where rare codon usage is not a critical factor, BL21(DE3) might provide a more efficient platform for protein expression.
The results indicate that the protein expression level in the BL21(DE3) strain is higher compared to that in the Rosetta strain.
Fig. 4 | Comparison of fusion protein expression in E. coli strains BL21(DE3) and Rosetta.
Lane 1: Protein ladder; Lanes 2-4 (BL21(DE3) LB 37℃ 4 h): Lane 2: Total liquid (IPTG); Lane 3: Supernatant (IPTG); Lane 4: Precipitate (IPTG); Lanes 5-7 (Rosetta LB 37℃ 4 h) Lane 5: Total liquid (IPTG); Lane 6: Supernatant (IPTG); Lane 7: Precipitate (IPTG)
Protein Purification
After considering both expression efficiency and practical experimental constraints, we decided to express the fusion protein at 37°C for 4 h in LB medium using the pET-SUMO-TRn4-mfp5 plasmid.
As shown in Figures 2-4, the target protein was present in the pellet after cell lysis. Therefore, we denatured the pellet of the fusion protein TRn4-mfp5 with 8M urea overnight and renatured it through dialysis. This process resulted in some protein loss, as confirmed by SDS-PAGE analysis.
Consequently, we proceeded to purify the fusion protein TRn4-mfp5 using a Ni-NTA Gravity Column.
The target protein bands were present in lanes 2 to 5, indicating successful expression of the target protein, with a particularly strong band in the supernatant after denaturation (Fig. 5, lane 7). After purification, the target protein was mainly found in the 150 mM and 300 mM imidazole elution fractions.
Fig. 5 | SDS-PAGE of purified fusion protein TRn4-mfp5(35.4 kDa) uses vector pET-SUMO.
Lane 1: Protein-Binding buffer; Lane 2: 20 mM imidazole and 8 M urea elution; Lane 3: 50 mM imidazole and 8 M urea elution; Lane 4: 150 mM imidazole and 8 M urea elution; Lane 5: 300 mM imidazole and 8 M urea elution; Lane 6: 500 mM imidazole and 8 M urea elution; Lane 7: Supernatant; Lane 8: Impurities; Lane 9: Protein ladder.
To further confirm the expression of TRn4-mfp5, we performed a Western blot, which provided a clear and definitive conclusion, verifying the successful expression of the TRn4-mfp5 protein under the conditions mentioned above.
Fig. 6 | Western Blot of purified fusion protein TRn4-mfp5(35.4 kDa) uses vector pET-SUMO.
a. Western blot of the pre-expressed protein. Lane 1: Total liquid (IPTG); Lane 2: Supernatant (IPTG); Lane 3: Precipitate (IPTG), b. Western blot after column purification of the supernatant following denaturation. Lane 1: Supernatant; Lane 2: 20 mM imidazole and 8 M urea elution; Lane 3: 50 mM imidazole and 8 M urea elution; Lane 4: 150 mM imidazole and 8 M urea elution; Lane 5: 300 mM imidazole and 8 M urea elution; Lane 6: 500 mM imidazole and 8 M urea elution.
Adhesive test
We obtained protein samples of TRn4-mfp5 by freezedrying 24 h (Fig. 7). We finally got about 25 mg protein from 1 L bacterial culture.
Fig. 7 | The protein sample freeze-dried by a lyophilizer.
Next, we dissolved protein samples in Buffer A (10 mL 20 mM Tris pH = 8) to reach 0.3 mg/mL, and conduct adhesive ability tests on the fusion protein(Fig. 8). 20 μL of the protein solution was applied, and the pipette tip was placed on a plastic Petri dish lid. After incubation at 37°C for 4 h, the pipette tip successfully adhered.
Fig. 8 | Adhesive ability test of fusion protein on plastic surface
https://video.igem.org/videos/embed/76ade119-0738-4ded-9b7e-1af2e0326a27
Video. 1 | NAU-CHINA: TRn4-mfp5 adhesive ability test (2024)
Surface Area Calculation:
The surface area for the annular region of the pipette tip is calculated as:
S = π × (router2 - rinner 2)
Where:
router = 3 mm = 0.3 cm
rinner = 1.85 mm = 0.185 cm
Substituting these values, we get:
S = π × (0.32 - 0.1852) = π × (0.09 - 0.034225) = π × 0.055775 ≈ 0.1753 cm2
Force Calculation:
The total force is calculated as:
F = (5.951 + 0.448 × 15) g × 9.8 N/kg = 12.671 g × 9.8 N/kg ≈ 0.12418 N
Adhesive Force Calculation:
The adhesive force produced by the protein is:
P = F / S = 0.12418 N / 0.1753 cm2 ≈ 0.708 N/cm2 = 7.08 kPa
Adhesive Force per Milligram of Protein:
The adhesive force per milligram of protein is:
P' = P / m = 7.08 kPa / 1 mg = 7.08 kPa/mg
Reference
[1] Jung H., Pena-Francesch A., Saadat A, et al. Molecular tandem repeat strategy for elucidating mechanical properties of high-strength proteins[J]. PNAS, 2016, 113(23), 6478–6483.
[2] Zhang C, Wu B, Zhou Y, et al. Mussel-inspired hydrogels: from design principles to promising applications[J]. Chem Soc Rev, 2020, 49(3605): 3605-3637.